2009 Outlook for Medical Companies Beijing Double-Crane Pharmaceutical Shanghai Kehua Bio-engineering Co.,Co.,Ltd.(Double Crane,SH:600062)Ltd.(Kehua,SZ:002022) Double Crane focuses on the pharmaceuti-cal sector.has completed a nationwide dis-tribution for the business of intravenoussolutions(Ⅳ solutions)of 1 00 millilitersor above,via acquiring GuangzhouShenzhou Pharmaceutical Co.,Ltd.andbuilding an Ⅳ solutions manufacturing basein Xinmin,Liaoning province.It is expectedthat the company’s market share for Ⅳ so-1utions would rise to around 20% in 2009from 12% in 2008.Meanwhile,as the firmhas largely hiked the production of plasticsbottles/bags with relatively higher profitmargins.The gross margin for its Ⅳ solu-tions business would rise to around 40% in